Semax is one of the most well-studied nootropic peptides in neuroscience research. Derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH), this synthetic peptide has demonstrated remarkable effects on brain-derived neurotrophic factor (BDNF) expression, cognitive function, and neuroprotection in extensive preclinical and clinical research conducted primarily in Russia, where it is approved for clinical use.
What is Semax?
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) corresponding to the ACTH(4-7) fragment with an added Pro-Gly-Pro tripeptide extension. This modification dramatically improves metabolic stability while preserving the cognitive-enhancing properties of the parent ACTH fragment. It was developed at the Russian Academy of Sciences and has been the subject of over 100 research publications.
Mechanism of Action
BDNF Upregulation
Semax's most significant mechanism is its ability to upregulate brain-derived neurotrophic factor (BDNF) — a critical protein for neuronal survival, synaptic plasticity, and cognitive function. Research shows Semax increases BDNF levels in the hippocampus, prefrontal cortex, and other brain regions associated with learning and memory.
Serotonin System Modulation
Semax influences the serotonergic system, affecting genes involved in serotonin metabolism and signaling. This contributes to its mood-stabilizing properties and is relevant to research on anxiety and emotional regulation.
NGF Expression
Research demonstrates Semax increases expression of nerve growth factor (NGF) and its receptor TrkA, supporting neuronal survival and differentiation.
Research Applications
Cognitive Enhancement
Semax has been studied extensively for its effects on attention, memory consolidation, learning speed, and cognitive performance under stress conditions.
Neuroprotection
Research models demonstrate Semax's neuroprotective properties in cerebral ischemia, oxidative stress, and excitotoxicity — making it relevant for stroke recovery and neurodegeneration research.
Optic Nerve Research
Clinical research in Russia has examined Semax's effects on optic nerve function, including studies in glaucoma and optic neuropathy models.
Semax vs. NA Semax Amidate
AltPeptide offers both standard Semax and NA Semax amidate. The amidated version features N-acetylation and C-terminal amidation that further improve stability and bioavailability. See our comparison guide for details.
Available Dosages
Standard Semax: 5mg, 10mg, 30mg. Also available as a Semax + Selank blend (20mg) combining cognitive enhancement with anxiolytic effects.
Conclusion
Semax's ability to upregulate BDNF, enhance cognitive function, and provide neuroprotection makes it one of the most valuable nootropic peptides in neuroscience research. Its extensive research base and multiple available dosages support a wide range of cognitive and neuroprotection studies.
Source Research-Grade Semax
AltPeptide offers Semax in multiple research-grade formulations. All products are third-party assayed, lyophilized for stability, and shipped with DDP worldwide delivery.
All compounds are sold for laboratory research purposes only. Not for human or animal consumption.
All compounds mentioned are sold for in-vitro laboratory research only. Not for human or animal consumption. Not approved by FDA or any regulator for therapeutic use. This article is for educational and informational purposes only.